Kedudukan dalam Saham
#21789
BioPorto A/S is a Danish in-vitro diagnostics specialist, supplying biomarker... BioPorto A/S is a Danish in-vitro diagnostics specialist, supplying biomarker tests, research tools, and antibodies to medical professionals and scientists worldwide, with operations across Europe, North America, and Asia. Among its offerings is the neutrophil gelatinase-associated lipocalin (NGAL) test, a precise quantitative particle-enhanced turbidimetric immunoassay designed for use on automated chemistry analyzers. The company further provides monoclonal antibodies essential for scientific, pharmaceutical, and clinical investigations. Additionally, BioPorto produces enzyme-linked immunosorbent assay (ELISA) kits and a versatile rapid assay device tailored for custom lateral flow assay development. Established in 1917, the company is headquartered in Hellerup, Denmark.
Harga Saham
$0.20243542
Disegerakkan terakhir: 2026-08-21
Perubahan (1 tahun)
-0.82%
Perdagangan BioPorto A/S (BIOPOR)
Harga BIOPOR dengan permodalan pasaran b
Modal pasaran bagi BioPorto A/S(BIOPOR)
Modal Pasaran: $100.22M
Sehingga August 2026, BioPorto A/S mempunyai modal pasaran sebanyak $100.22M. Ini menjadikan BioPorto A/S syarikat ke-21789th paling bernilai di dunia mengikut data kami. Kapitalisasi pasaran ialah nilai keseluruhan saham syarikat tersenarai yang berada dalam edaran dan lazimnya digunakan untuk menilai nilai syarikat tersebut.
Sejarah modal pasaran BioPorto A/S dari 2000 hingga 2026
BIOPOR berbanding dengan 5 teratas yang paling popular stocks
| Harga BIOPOR |
|
Aset B |
Pasaran B |
Hasilnya |
|
|
|
|
$5.211T
|
+5,199,594.16%
|
|
|
|
|
$4.547T
|
+4,536,460.17%
|
|
|
|
|
$4.162T
|
+4,153,051.01%
|
|
|
|
|
$3.593T
|
+3,584,642.00%
|
|
|
|
|
$2.793T
|
+2,786,497.65%
|
